DNPUF OTC
Sumitomo Pharma Co., Ltd.
1W: +0.0%
1M: +5.6%
3M: +4.0%
YTD: -31.8%
1Y: -15.5%
3Y: +54.7%
5Y: -45.3%
$9.79
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$809.6B
+9.0% ▲
5Y CAGR: -9.1%
Total Liabilities
$515.3B
-10.1% ▼
5Y CAGR: -4.8%
Shareholders Equity
$294.3B
+73.7% ▲
5Y CAGR: -12.7%
Cash & Investments
$44.6B
+11.6% ▲
5Y CAGR: -27.5%
Total Debt
$218.6B
-28.4% ▼
5Y CAGR: -4.4%
Net Debt
$174.0B
-38.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $203.0B | $143.5B | $29.0B | $23.1B | $44.6B |
| Short-Term Investments | $35.6B | $20.2B | $7.1B | $16.8B | $0 |
| Cash & ST Investments | $238.6B | $163.7B | $36.1B | $40.0B | $44.6B |
| Net Receivables | $151.4B | $95.9B | $81.0B | $74.8B | $135.5B |
| Inventory | $99.0B | $94.4B | $115.3B | $94.2B | $86.0B |
| Other Current Assets | $10.5B | $27.9B | $37.1B | $44.1B | $14.9B |
| Total Current Assets | $499.5B | $381.9B | $269.6B | $253.2B | $281.0B |
| Property, Plant & Equip. | $64.1B | $58.9B | $57.9B | $46.6B | $44.5B |
| Goodwill & Intangibles | $593.8B | $538.7B | $395.4B | $369.9B | $373.9B |
| Long-Term Investments | $80.2B | $113.8B | $182.4B | $72.3B | $81.6B |
| Other Non-Current Assets | $47.7B | $30.6B | $0 | $0 | $28.2B |
| Total Non-Current Assets | $808.5B | $752.9B | $637.9B | $489.4B | $528.6B |
| Total Assets | $1.31T | $1.13T | $907.5B | $742.6B | $809.6B |
| — Liabilities — | |||||
| Accounts Payable | $46.2B | $52.1B | $67.7B | $38.5B | $57.1B |
| Short-Term Debt | $25.1B | $90.6B | $285.5B | $46.4B | $38.4B |
| Deferred Revenue | $140.0B | $152.0B | $1.3B | $0 | $0 |
| Other Current Liabilities | $67.1B | $78.0B | $157.1B | $154.0B | $176.7B |
| Total Current Liabilities | $278.4B | $372.7B | $515.5B | $240.6B | $273.2B |
| Long-Term Debt | $244.0B | $244.1B | $133.4B | $259.0B | $180.2B |
| Other Non-Current Liab. | $74.1B | $52.6B | $92.1B | $47.0B | $46.0B |
| Total Non-Current Liabilities | $356.1B | $357.1B | $235.9B | $332.5B | $242.1B |
| Total Liabilities | $634.4B | $728.0B | $751.4B | $573.1B | $515.3B |
| — Equity — | |||||
| Common Stock | $22.4B | $22.4B | $22.4B | $22.4B | $22.5B |
| Retained Earnings | $514.2B | $281.0B | -$22.7B | $46.8B | $160.0B |
| Accumulated OCI | $55.2B | $104.0B | $157.0B | $101.0B | $112.5B |
| Total Stockholders Equity | $607.9B | $406.7B | $156.1B | $169.5B | $294.3B |
| Total Liabilities & Equity | $1.31T | $1.13T | $907.5B | $742.6B | $809.6B |
| — Key Metrics — | |||||
| Total Debt | $269.0B | $334.7B | $427.9B | $305.4B | $218.6B |
| Net Debt | $66.1B | $191.2B | $398.8B | $282.3B | $174.0B |
| Total Investments | $115.8B | $134.0B | $189.5B | $89.2B | $81.6B |